EP2102651A4 - Procédés et systèmes d'analyse génétique - Google Patents

Procédés et systèmes d'analyse génétique

Info

Publication number
EP2102651A4
EP2102651A4 EP07854875A EP07854875A EP2102651A4 EP 2102651 A4 EP2102651 A4 EP 2102651A4 EP 07854875 A EP07854875 A EP 07854875A EP 07854875 A EP07854875 A EP 07854875A EP 2102651 A4 EP2102651 A4 EP 2102651A4
Authority
EP
European Patent Office
Prior art keywords
methods
genetic analysis
analysis systems
systems
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP07854875A
Other languages
German (de)
English (en)
Other versions
EP2102651A2 (fr
Inventor
Dietrich A Stephan
Melissa Floren Filippone
Jennifer Wessel
Michele Cargill
Eran Halperin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Navigenics Inc
Original Assignee
Navigenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/781,679 external-priority patent/US20080131887A1/en
Application filed by Navigenics Inc filed Critical Navigenics Inc
Publication of EP2102651A2 publication Critical patent/EP2102651A2/fr
Publication of EP2102651A4 publication Critical patent/EP2102651A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioethics (AREA)
  • Databases & Information Systems (AREA)
  • Ecology (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
EP07854875A 2006-11-30 2007-11-30 Procédés et systèmes d'analyse génétique Ceased EP2102651A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US86806606P 2006-11-30 2006-11-30
US95112307P 2007-07-20 2007-07-20
US11/781,679 US20080131887A1 (en) 2006-11-30 2007-07-23 Genetic Analysis Systems and Methods
US97219807P 2007-09-13 2007-09-13
US98562207P 2007-11-05 2007-11-05
US98968507P 2007-11-21 2007-11-21
PCT/US2007/086138 WO2008067551A2 (fr) 2006-11-30 2007-11-30 Procédés et systèmes d'analyse génétique

Publications (2)

Publication Number Publication Date
EP2102651A2 EP2102651A2 (fr) 2009-09-23
EP2102651A4 true EP2102651A4 (fr) 2010-11-17

Family

ID=38962435

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07854875A Ceased EP2102651A4 (fr) 2006-11-30 2007-11-30 Procédés et systèmes d'analyse génétique

Country Status (10)

Country Link
EP (1) EP2102651A4 (fr)
JP (2) JP2010522537A (fr)
KR (1) KR20090105921A (fr)
CN (1) CN103642902B (fr)
AU (1) AU2007325021B2 (fr)
CA (1) CA2671267A1 (fr)
GB (1) GB2444410B (fr)
HK (1) HK1139737A1 (fr)
TW (1) TWI363309B (fr)
WO (1) WO2008067551A2 (fr)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8340950B2 (en) 2006-02-10 2012-12-25 Affymetrix, Inc. Direct to consumer genotype-based products and services
US20080131887A1 (en) 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
WO2008103299A2 (fr) 2007-02-16 2008-08-28 Massachusetts Eye & Ear Infirmary Procédés et compositions pour pronostiquer, détecter et traiter une dégénérescence maculaire liée à l'âge
US7844609B2 (en) 2007-03-16 2010-11-30 Expanse Networks, Inc. Attribute combination discovery
FR2934698B1 (fr) * 2008-08-01 2011-11-18 Commissariat Energie Atomique Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede.
CN102171697A (zh) * 2008-08-08 2011-08-31 纳维哲尼克斯公司 用于个性化行动计划的方法和系统
EP2335174A1 (fr) * 2008-09-12 2011-06-22 Navigenics INC. Procédés et systèmes permettant d'intégrer de multiples facteurs de risques environnementaux et génétiques
NZ572036A (en) 2008-10-15 2010-03-26 Nikola Kirilov Kasabov Data analysis and predictive systems and related methodologies
US8367333B2 (en) * 2008-12-12 2013-02-05 Decode Genetics Ehf. Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction
US8108406B2 (en) 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
EP3276526A1 (fr) 2008-12-31 2018-01-31 23Andme, Inc. Recherche de parents dans une base de données
CA2760439A1 (fr) 2009-04-30 2010-11-04 Good Start Genetics, Inc. Procedes et compositions d'evaluation de marqueurs genetiques
EP2438193B1 (fr) * 2009-06-01 2015-07-22 Genetic Technologies Limited Procédés destinés à évaluer les risques de cancer du sein
DE102010013114B4 (de) * 2010-03-26 2012-02-16 Rüdiger Lawaczeck Prädiagnostisches Sicherheitssystem
KR20110136638A (ko) * 2010-06-15 2011-12-21 재단법인 게놈연구재단 게놈정보를 이용하여 온라인 상의 사회적 네트워크를 형성하는 시스템 및 그 형성방법
WO2012006669A1 (fr) * 2010-07-13 2012-01-19 Fitgenes Pty Ltd Système et procédé permettant d'établir une stratégie personnelle d'intervention sur la santé
WO2012030967A1 (fr) * 2010-08-31 2012-03-08 Knome, Inc. Indexeur génomique personnel
US20120309641A1 (en) 2010-10-19 2012-12-06 Medtronic, Inc. Diagnostic kits, genetic markers, and methods for scd or sca therapy selection
CN103314383A (zh) * 2010-11-01 2013-09-18 皇家飞利浦电子股份有限公司 包括专有测试的特许使用费的自动化代理的体外诊断测试
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
US8718950B2 (en) 2011-07-08 2014-05-06 The Medical College Of Wisconsin, Inc. Methods and apparatus for identification of disease associated mutations
US20140310215A1 (en) * 2011-09-26 2014-10-16 John Trakadis Method and system for genetic trait search based on the phenotype and the genome of a human subject
WO2013055911A1 (fr) 2011-10-14 2013-04-18 Dana-Farber Cancer Institute, Inc. Biomarqueur znf365/zfp365 pouvant prévoir une réponse anticancéreuse
KR101295785B1 (ko) * 2011-10-31 2013-08-12 삼성에스디에스 주식회사 유전변이 데이터 베이스 구축 장치 및 방법
US10437858B2 (en) 2011-11-23 2019-10-08 23Andme, Inc. Database and data processing system for use with a network-based personal genetics services platform
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
KR20140009854A (ko) * 2012-07-13 2014-01-23 삼성전자주식회사 치료제 선정을 위한 유전 정보의 분석 방법 및 장치
KR101967248B1 (ko) * 2012-08-16 2019-04-10 삼성전자주식회사 개인의 유전 정보를 분석하는 방법 및 장치
JP5844715B2 (ja) 2012-11-07 2016-01-20 学校法人沖縄科学技術大学院大学学園 データ通信システム、データ解析装置、データ通信方法、および、プログラム
KR101533395B1 (ko) * 2013-01-21 2015-07-08 이상열 단일 염기 다형성을 이용한 개체간의 유사도 산출 방법 및 시스템
WO2014119914A1 (fr) * 2013-02-01 2014-08-07 에스케이텔레콤 주식회사 Procédé permettant de fournir des informations sur un marqueur personnel basé sur une séquence de gènes et appareil l'utilisant
WO2014152421A1 (fr) 2013-03-14 2014-09-25 Good Start Genetics, Inc. Procédés d'analyse d'acides nucléiques
US20140274763A1 (en) * 2013-03-15 2014-09-18 Pathway Genomics Corporation Method and system to predict response to pain treatments
US9192647B2 (en) 2013-10-04 2015-11-24 Hans-Michael Dosch Method for reversing recent-onset type 1 diabetes (T1D) by administering substance P (sP)
TW201516725A (zh) * 2013-10-18 2015-05-01 Tci Gene Inc 單一核苷酸多型性疾病發生率預測系統
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
FI20136079A (fi) * 2013-11-04 2015-05-05 Medisapiens Oy Menetelmä ja järjestelmä geeniperimän terveyden arvioimiseksi
DE202014010499U1 (de) 2013-12-17 2015-10-20 Kymab Limited Targeting von humaner PCSK9 zur Cholesterinbehandlung
KR101400946B1 (ko) * 2013-12-27 2014-05-29 한국과학기술정보연구원 생물학적 네트워크 분석 장치 및 방법
KR102131973B1 (ko) * 2013-12-30 2020-07-08 주식회사 케이티 개인 건강관리 방법 및 시스템
CN106460062A (zh) 2014-05-05 2017-02-22 美敦力公司 用于scd、crt、crt‑d或sca治疗识别和/或选择的方法和组合物
US11053548B2 (en) 2014-05-12 2021-07-06 Good Start Genetics, Inc. Methods for detecting aneuploidy
EP4328245A3 (fr) 2014-07-15 2024-06-05 Kymab Ltd. Anticorps utilisés dans le traitement de pathologies associées à des variants pcsk9 spécifiques dans des populations de patients spécifiques
DE202015009002U1 (de) 2014-07-15 2016-08-18 Kymab Limited Targeting von humaner PCSK9 zur Cholesterinbehandlung
EP2975059A1 (fr) 2014-07-15 2016-01-20 Kymab Limited Anticorps pour utilisation dans le traitement de maladies liées à certains variants spécifiques de pcsk9 dans certaines populations spécifiques de patients
WO2016023916A1 (fr) 2014-08-12 2016-02-18 Kymab Limited Traitement de maladie par la liaison d'un ligand à des cibles présentant un intérêt
US20180032673A1 (en) * 2014-09-03 2018-02-01 Otsuka Pharmaceutical Co., Ltd. Pathology determination assistance device, method and storage medium
WO2016040446A1 (fr) 2014-09-10 2016-03-17 Good Start Genetics, Inc. Procédés permettant la suppression sélective de séquences non cibles
CA2999708A1 (fr) 2014-09-24 2016-03-31 Good Start Genetics, Inc. Commande de procede pour accroitre la robustesse de tests genetiques
WO2016071701A1 (fr) 2014-11-07 2016-05-12 Kymab Limited Traitement de maladie par liaison de ligand à des cibles d'intérêt
CA3010579A1 (fr) 2015-01-06 2016-07-14 Good Start Genetics, Inc. Criblage de variants structuraux
WO2016118527A1 (fr) 2015-01-20 2016-07-28 Nantomics, Llc Systèmes et procédés pour une prédiction de réponse à une chimiothérapie dans un cancer de la vessie de haut degré
EP3256606B1 (fr) * 2015-02-09 2019-05-22 10X Genomics, Inc. Systèmes et procédés pour déterminer la variation structurale
KR20190047108A (ko) * 2015-03-03 2019-05-07 난토믹스, 엘엘씨 앙상블-기반 연구 추천 시스템 및 방법
KR102508971B1 (ko) * 2015-07-22 2023-03-09 주식회사 케이티 질병 위험도 예측 방법 및 이를 수행하는 장치
CA3035342A1 (fr) * 2015-09-16 2017-03-23 Good Start Genetics, Inc. Systemes et procedes pour tests genetiques medicaux
EP3350721A4 (fr) * 2015-09-18 2019-06-12 Fabric Genomics, Inc. Prédiction de charge de maladie à partir de variantes du génome
KR101795662B1 (ko) * 2015-11-19 2017-11-13 연세대학교 산학협력단 대사 이상 질환 진단 장치 및 그 방법
FR3045874B1 (fr) * 2015-12-18 2019-06-14 Axlr, Satt Du Languedoc Roussillon Architecture pour l'analyse de donnees genomiques
JP6776576B2 (ja) * 2016-03-28 2020-10-28 富士通株式会社 データベース処理プログラム、データベース処理装置及びデータベース処理方法
KR101991007B1 (ko) * 2016-05-27 2019-06-20 (주)메디젠휴먼케어 Snp를 이용한 질병 관련 유전체 분석 시스템 및 장치
EP3479272A1 (fr) * 2016-06-29 2019-05-08 Koninklijke Philips N.V. Anonymisation génomique orientée maladie
KR101815529B1 (ko) 2016-07-29 2018-01-30 (주)신테카바이오 휴먼 하플로타이핑 시스템 및 방법
WO2018042185A1 (fr) * 2016-09-02 2018-03-08 Imperial Innovations Ltd Procédés, systèmes et appareil d'identification de variantes de gènes pathogènes
CN106778083A (zh) * 2016-11-28 2017-05-31 墨宝股份有限公司 一种自动生成基因检测报告的方法及装置
WO2018110490A1 (fr) * 2016-12-12 2018-06-21 日本電気株式会社 Dispositif de traitement d'informations, procédé de création d'informations génétique et programme
JP7264046B2 (ja) * 2017-03-15 2023-04-25 東洋紡株式会社 遺伝子検査方法及び遺伝子検査キット
CN108629153A (zh) * 2017-03-23 2018-10-09 广州康昕瑞基因健康科技有限公司 医学基因分析方法和系统
AU2018315056B2 (en) * 2017-08-08 2021-06-17 Queensland University Of Technology Methods for diagnosis of early stage heart failure
KR102073590B1 (ko) * 2017-08-17 2020-02-06 (주)에이엔티홀딩스 유전자 정보에 기초하여 서비스를 제공하기 위한 방법, 시스템 및 비일시성의 컴퓨터 판독 가능 기록 매체
KR102097540B1 (ko) * 2017-12-26 2020-04-07 주식회사 클리노믹스 질병 및 표현형 위험도 예측 장치 및 방법
CN108549795A (zh) * 2018-03-13 2018-09-18 刘吟 基于家系图框架的遗传咨询信息系统
GB201810897D0 (en) * 2018-07-03 2018-08-15 Chronomics Ltd Phenotype prediction
CN109355368A (zh) * 2018-10-22 2019-02-19 江苏美因康生物科技有限公司 一种快速检测高血压个体化用药基因多态性的试剂盒及方法
EP3874510A4 (fr) 2018-10-31 2022-08-03 Ancestry.com DNA, LLC Estimation de phénotypes à l'aide de l'adn, du pedigree et de données historiques
GB2578727A (en) * 2018-11-05 2020-05-27 Earlham Inst Genomic analysis
EP3899039A4 (fr) * 2018-12-20 2022-09-14 The Johns Hopkins University Traitement du diabète de type 1, et d'autres maladies auto-immunes
JP7137520B2 (ja) * 2019-04-23 2022-09-14 ジェネシスヘルスケア株式会社 膵炎のリスクを判定する方法
JP7137526B2 (ja) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 アトピー性皮膚炎のリスクを判定する方法
JP7137522B2 (ja) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 脊椎側弯症のリスクを判定する方法
JP7137521B2 (ja) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 乾癬のリスクを判定する方法
JP7137524B2 (ja) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 変形性膝関節症のリスクを判定する方法
JP7137523B2 (ja) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 じんましんのリスクを判定する方法
JP7137525B2 (ja) * 2019-04-24 2022-09-14 ジェネシスヘルスケア株式会社 接触性皮膚炎のリスクを判定する方法
KR102357453B1 (ko) * 2019-06-24 2022-02-04 (주) 아이크로진 유전 정보를 이용한 시각화 방법 및 시각화 서비스 플랫폼
KR102091790B1 (ko) * 2019-09-02 2020-03-20 주식회사 클리노믹스 피검사자와 생물체 간의 유전자 정보를 이용한 유전적 띠 제공 시스템 및 그 방법
KR102151716B1 (ko) * 2019-12-06 2020-09-04 주식회사 클리노믹스 게놈 정보를 이용한 유전적 성씨 정보 제공 시스템 및 방법
KR102179850B1 (ko) * 2019-12-06 2020-11-17 주식회사 클리노믹스 구강 내 미생물 분석장치를 이용한 건강 예측 시스템 및 방법
KR102136207B1 (ko) * 2019-12-31 2020-07-21 주식회사 클리노믹스 유전자 정보 개인 맞춤형 소셜 컨텐츠 정보 제공 시스템 및 그 방법
KR102138165B1 (ko) * 2020-01-02 2020-07-27 주식회사 클리노믹스 국가, 민족, 및 인종별 표준게놈지도를 이용한 정체성 분석 서비스 제공 방법
KR102223362B1 (ko) * 2020-08-10 2021-03-05 주식회사 쓰리빌리언 증상 연관 유전변이를 이용한 질병 유발 유전변이 발굴 시스템 및 방법
KR102223361B1 (ko) * 2020-09-23 2021-03-05 주식회사 쓰리빌리언 유전자 네트워크를 활용한 유전질병 진단 시스템
CN113921143B (zh) * 2021-10-08 2024-04-16 天津金域医学检验实验室有限公司 一种共分离分析中Bayes因子的个性化估算方法及系统
CN114360732B (zh) * 2022-01-12 2024-04-09 平安科技（深圳）有限公司 医疗数据分析方法、装置、电子设备及存储介质

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026029A2 (fr) * 1999-10-01 2001-04-12 Orchid Biosciences, Inc. Procede et systeme permettant de fournir sur un reseau informatique des renseignements cliniques sur le genotype
US20050214811A1 (en) * 2003-12-12 2005-09-29 Margulies David M Processing and managing genetic information

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000067139A (ja) * 1998-08-25 2000-03-03 Hitachi Ltd 電子カルテシステム
CA2420717C (fr) * 1999-08-27 2010-07-27 Iris Biotechnologies, Inc. Systeme d'intelligence artificielle pour l'analyse genetique
US20030208454A1 (en) * 2000-03-16 2003-11-06 Rienhoff Hugh Y. Method and system for populating a database for further medical characterization
JP2002107366A (ja) * 2000-10-02 2002-04-10 Hitachi Ltd 診断支援システム
AU2001297684A1 (en) * 2000-12-04 2002-08-19 Genaissance Pharmaceuticals, Inc. System and method for the management of genomic data
US20020128860A1 (en) * 2001-01-04 2002-09-12 Leveque Joseph A. Collecting and managing clinical information
US20020187483A1 (en) * 2001-04-20 2002-12-12 Cerner Corporation Computer system for providing information about the risk of an atypical clinical event based upon genetic information
US7461006B2 (en) * 2001-08-29 2008-12-02 Victor Gogolak Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
AU2002363329A1 (en) * 2001-11-06 2003-05-19 Elizabeth Gray Pharmacogenomics-based system for clinical applications
US20040053263A1 (en) * 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
JPWO2004109551A1 (ja) * 2003-06-05 2006-07-20 株式会社日立ハイテクノロジーズ 塩基配列関連情報を用いた情報提供システム及びプログラム
GB0313964D0 (en) * 2003-06-16 2003-07-23 Mars Inc Genotype test
US7084264B2 (en) * 2003-07-16 2006-08-01 Chau-Ting Yeh Viral sequences
US8222005B2 (en) * 2003-09-17 2012-07-17 Agency For Science, Technology And Research Method for gene identification signature (GIS) analysis
CN1867922A (zh) * 2003-10-15 2006-11-22 株式会社西格恩波斯特 疾病危险度判定用基因多态的确定方法、疾病危险度判定方法及判定用阵列
US7127355B2 (en) * 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis
CA2573945A1 (fr) * 2004-07-16 2006-01-26 Bayer Healthcare Ag Polymorphismes de nucleotides simples en tant qu'outil de pronostic pour diagnostiquer des reactions indesirables a un medicament (eim) et l'efficacite d'un medicament
WO2006053955A2 (fr) * 2004-11-19 2006-05-26 Oy Jurilab Ltd Procede et kit de detection d'un risque d'hypertension arterielle essentielle

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026029A2 (fr) * 1999-10-01 2001-04-12 Orchid Biosciences, Inc. Procede et systeme permettant de fournir sur un reseau informatique des renseignements cliniques sur le genotype
US20050214811A1 (en) * 2003-12-12 2005-09-29 Margulies David M Processing and managing genetic information

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CATHRYN LEWIS: "Genetic association studies: Design, analysis and interpretation", BRIEFINGS IN BIOINFORMATICS, vol. 3, no. 2, 1 June 2002 (2002-06-01), pages 146 - 153, XP055094751 *
HAMOSH A ET AL: "Online Mendelian Inheritance in Man (OMIM)", HUMAN MUTATION, JOHN WILEY & SONS, INC, US, vol. 15, no. 1, 1 January 2000 (2000-01-01), pages 57 - 61, XP002603004, ISSN: 1059-7794 *
HAMOSH A ET AL: "Online Mendelian Inheritance in Man (OMIM).", HUMAN MUTATION 2000 LNKD- PUBMED:10612823, vol. 15, no. 1, 2000, pages 57 - 61, XP002603004, ISSN: 1059-7794 *

Also Published As

Publication number Publication date
JP2010522537A (ja) 2010-07-08
CN103642902A (zh) 2014-03-19
AU2007325021A1 (en) 2008-06-05
GB0723512D0 (en) 2008-01-09
TWI363309B (en) 2012-05-01
WO2008067551A2 (fr) 2008-06-05
EP2102651A2 (fr) 2009-09-23
CA2671267A1 (fr) 2008-06-05
KR20090105921A (ko) 2009-10-07
JP2014140387A (ja) 2014-08-07
WO2008067551A3 (fr) 2008-12-11
CN103642902B (zh) 2016-01-20
HK1139737A1 (en) 2010-09-24
AU2007325021B2 (en) 2013-05-09
GB2444410A (en) 2008-06-04
GB2444410B (en) 2011-08-24
TW200847056A (en) 2008-12-01

Similar Documents

Publication Publication Date Title
HK1139737A1 (en) Genetic analysis systems and methods
ZA200903761B (en) Genetic analysis systems and methods
EP2030011A4 (fr) Système et procédés pour analyser des nanoreporteurs
GB2447820B (en) Well control systems and associated methods
EP2126702A4 (fr) Analyse et gestion de système
GB201109816D0 (en) System and method
EP2043519A4 (fr) Systèmes et procédés d'évaluation de paralysie
EP1986735A4 (fr) Systèmes et procédés de réduction de volume
EP2074577A4 (fr) Systèmes et procédés de paiement
ZA200805990B (en) New method and system
EP1976782A4 (fr) Systemes et procedes de deviation d'objets
GB2439644B (en) Input evaluation system and input evaluation method
EP1977359A4 (fr) Procedes et systemes de conduite d'operations de recherche
IL197284A0 (en) Disinfectant systems and methods
EP2029964A4 (fr) Systèmes et procédés pour des matériaux lumineux
ZA200906118B (en) Descenting systems and methods
GB2441091B (en) Methods and systems for putting analysis
EP2142660A4 (fr) Procédés et systèmes pour la o-glycosylation de protéines
GB0905005D0 (en) Advisory systems and methods
ZA200806800B (en) Systems and methods for diverting objects
TWI319540B (en) Interaction system and method
EP2092480A4 (fr) Système et procédé de transaction
EP2020167A4 (fr) Systèmes et procédés génériques à blindage anti-électromagnétique
GB0623059D0 (en) Database system and method
GB0909190D0 (en) Oilfield analysis system and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090630

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 19/00 20060101AFI20101001BHEP

Ipc: G01N 33/48 20060101ALI20101001BHEP

Ipc: C12Q 1/68 20060101ALN20101001BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20101020

17Q First examination report despatched

Effective date: 20140113

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20170516